Department of Infectious Diseases, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, People's Republic of China.
Key Laboratory of Microbial Technology and Bioinformatics of Zhejiang Province, Hangzhou, People's Republic of China.
Emerg Microbes Infect. 2024 Dec;13(1):2339942. doi: 10.1080/22221751.2024.2339942. Epub 2024 Apr 16.
To investigate the epidemiology of ST20 carbapenem-resistant (CRKP) in China, and further explore the genomic characteristics of and coharboring isolates and plasmid contributions to resistance and fitness. Seven ST20 CRKP isolates were collected nationwide, and antimicrobial susceptibility testing was performed. Antimicrobial resistance genes, virulence genes, and plasmid replicons were identified via whole-genome sequencing, and clonality assessed via core-genome multilocus sequence typing. Furthermore, we found four dual-metallo-β-lactamases (MBL)-harbouring isolates, the gene location was detected by Southern blotting, and plasmid location analysis showed that was located on a separate plasmid, a self-conjugative fusion plasmid, or the bacterial chromosome. These isolates were subjected to long-read sequencing, the presence of in different locations was identified by genomic comparison, and transposon units were detected via inverse PCR. We subsequently found that on the fusion plasmid and bacterial chromosome was formed via intact plasmid recombination by the IS and , respectively, and the circular transposon unit was related to cointegration, however, in different locations did not affect the gene stability. The -harbouring plasmid contributed to the increased resistance to β-lactams and shortened survival lag time which was revealed in plasmid cured isolates. In summary, the ST20 clone is a high-risk resistant clone. With the use of ceftazidime/avibactam, MBL-positive isolates, especially dual-MBL-harbouring isolates, should be given additional attention.
为了调查中国 ST20 碳青霉烯耐药(CRKP)的流行病学情况,并进一步探讨同时携带 和 的分离株的基因组特征以及质粒对耐药性和适应性的贡献。本研究在全国范围内收集了 7 株 ST20 CRKP 分离株,并进行了药敏试验。通过全基因组测序鉴定了抗菌药物耐药基因、毒力基因和质粒复制子,并通过核心基因组多位点序列分型评估了克隆性。此外,我们发现了 4 株同时携带两种金属β-内酰胺酶(MBL)的分离株,通过 Southern 印迹检测到基因位置,质粒定位分析显示 位于一个单独的质粒、自我接合融合质粒或细菌染色体上。这些分离株进行了长读测序,通过基因组比较鉴定了不同位置的 存在情况,并通过反向 PCR 检测了转座子单元。随后发现,融合质粒和细菌染色体上的 分别通过 IS 和 ,完整质粒重组形成,而圆形转座子单元与共整合有关,但是不同位置的 并不影响基因稳定性。携带 的质粒有助于增加对β-内酰胺类药物的耐药性,并缩短生存滞后时间,这在质粒消除的分离株中得到了证实。综上所述,ST20 克隆是一种高风险的耐药克隆。在使用头孢他啶/阿维巴坦时,应特别关注产 MBL 的分离株,尤其是同时携带两种 MBL 的分离株。